A Bifidobacterium Strain with Antibacterial Activity, Its Antibacterial Characteristics and In Vitro Probiotics Studies

Jing Ji, Tiange Li, Baoying Ma, Runzhong WangMicroorganisms 2025 · DOI

TL;DR

This study identifies Bifidobacterium sp. strain TF04 as a potent natural antimicrobial agent, demonstrating significant inhibitory effects against common pathogens like E. coli and S. aureus. Beyond its antibacterial prowess, TF04 exhibits robust probiotic characteristics, including acid and bile tolerance, strong adhesion potential, and antioxidant activity, making it a promising candidate for food preservation and functional foods.

What Problem Does This Paper Address?

The increasing demand for food safety and consumer concerns about synthetic preservatives are driving the search for natural antimicrobial alternatives. Pathogenic bacteria and microbial spoilage pose significant threats to food quality, safety, and economic value. Probiotics, known for their health benefits, also offer potential as natural "bacteriostats" to control microbial growth in food. However, identifying strains with both potent antimicrobial activity and desirable probiotic traits, along with understanding their stability and mechanisms, remains a key challenge. This paper addresses this by screening probiotic strains for antibacterial activity and thoroughly characterizing a promising Bifidobacterium isolate.

Methods

The researchers screened 23 probiotic strains for their ability to inhibit the growth of Escherichia coli, Staphylococcus aureus, and Staphylococcus epidermidis using the agar well diffusion assay. The most effective strain, TF04, was then subjected to a series of in-depth analyses:

  • Strain Identification: 16S rRNA gene sequencing and phylogenetic analysis were used to identify the strain.
  • Antimicrobial Substance Characterization: Experiments were conducted to exclude organic acids and hydrogen peroxide as the primary antimicrobial factors. This involved adjusting pH with organic acids and treating the antimicrobial agent with catalase.
  • Protease Sensitivity: The antimicrobial agent was treated with various proteases (pepsin, trypsin, proteinase K, alkaline protease, papain) to determine if the active compounds were proteinaceous.
  • Stability Tests: The bacteriostatic agent's stability was assessed under varying pH conditions (acid-base stability), temperatures (thermal stability), and UV irradiation (ultraviolet stability).
  • Probiotic Analysis: Key probiotic characteristics were evaluated, including:
  • Acid and Bile Salt Tolerance: Survival rates were measured under simulated gastrointestinal conditions (low pH and bile salts).
  • Auto-Aggregation and Hydrophobicity: These assays assess the strain's ability to adhere to surfaces and colonize the gut.
  • Safety Assessment: Hemolytic and gelatinase activities were tested to ensure the strain's safety.
  • Antioxidant Activity: DPPH and hydroxyl radical scavenging assays were performed to evaluate the strain's antioxidant potential.

Datasets

Not discussed in the paper. The study utilized standard bacterial strains (E. coli ATCC 25922, S. aureus ATCC 12600, and S. epidermidis ATCC 8032) and 23 probiotic strains preserved by Tianda Tianfu Biotechnology Co., Ltd.

Key Insights and Ideas

  • TF04: A Dual-Threat Probiotic: The discovery of Bifidobacterium sp. strain TF04 is significant because it combines potent, broad-spectrum antibacterial activity with a suite of desirable probiotic traits. This "one-two punch" makes it a highly attractive candidate for applications where both food preservation and health benefits are desired.
  • Proteinaceous Antimicrobials: The susceptibility of TF04's antimicrobial activity to proteases strongly suggests that the active compounds are protein-based, likely bacteriocins or other antimicrobial peptides. This opens avenues for purification and characterization of these specific molecules.
  • Remarkable Stability: The bacteriostatic agent produced by TF04 exhibits impressive stability across a wide pH range (optimal at 2-4), high temperatures, and UV exposure. This robustness is crucial for its practical application in diverse food processing and storage conditions.
  • Gut Colonization Potential: TF04's ability to survive harsh gastrointestinal conditions (low pH, bile salts), coupled with its strong auto-aggregation and hydrophobicity, indicates a high likelihood of successful colonization in the human gut, a key characteristic of effective probiotics.
  • Safety First: The absence of hemolytic and gelatinase activities confirms TF04's safety profile, a critical prerequisite for any food-grade probiotic or antimicrobial agent.

Key Results

  • Bifidobacterium sp. strain TF04 demonstrated significant inhibition zones against E. coli (12.85 ± 0.12 mm), S. aureus (14.85 ± 0.10 mm), and S. epidermidis (17.50 ± 0.23 mm).
  • The antimicrobial activity was primarily attributed to proteinaceous compounds, as it was significantly reduced by protease treatment.
  • TF04 exhibited optimal bacteriostatic activity at pH 2-4, with good stability across a wide pH range.
  • The strain showed excellent survival rates: >45% viability at pH 2.0 and >55% survival in 3% bile salts.
  • Auto-aggregation reached 40.10% and hydrophobicity exceeded 30%, indicating strong gut colonization potential.
  • TF04 displayed notable antioxidant capacity, with DPPH scavenging activity of ~80% for bacterial suspension and ~50% for fermentation broth.
  • No hemolytic or gelatinase activity was detected, confirming its safety.

Limitations and Future Work

The authors acknowledge that the precise molecular structures and mechanisms of the antibacterial proteins/peptides produced by TF04 remain uncharacterized. Future work should prioritize:

  • Purification and Characterization: Isolating and identifying the specific bioactive compounds responsible for the antimicrobial activity.
  • Mechanism Elucidation: Further investigating the exact mechanisms by which these compounds inhibit bacterial growth (e.g., membrane disruption, enzyme inhibition).
  • Food System Validation: Testing the efficacy and stability of TF04 and its derived bacteriostats in actual food matrices to assess their practical application potential.
  • In Vivo Studies: Conducting animal or human trials to confirm the probiotic benefits and safety of TF04 in a living system.

Summary updated

Abstract

The search for natural antimicrobials has intensified with rising food safety demands. This study evaluated 23 probiotic strains, identifying <i>Bifidobacterium</i> sp. strain TF04 as a potent inhibitor against pathogens, with inhibition zone diameters of 12.85 ± 0.12 mm (<i>Escherichia coli</i>), 14.85 ± 0.10 mm (<i>Staphylococcus aureus</i>), and 17.50 ± 0.23 mm (<i>Staphylococcus epidermidis</i>). Preliminary analysis shows that the main antibacterial compounds produced by TF04 in the process of bacterial growth inhibition are antibacterial active proteins. TF04 exhibits optimal bacteriostatic activity within the pH range of 2-4, with a notable decline in effectiveness as the pH value increases. At the same time, the bacteriostat produced by TF04 showed strong thermal stability and ultraviolet stability. TF04 demonstrated excellent probiotic potential: surviving acidic (pH 2.0, >45% viability) and bile conditions (3% bile salts, >55% survival). It showed strong auto-aggregation (40.10%) and hydrophobicity (>30%), indicating gut colonization potential, along with notable antioxidant capacity. Safety was confirmed by absent hemolytic and gelatinase activities. These properties position TF04 as a promising multifunctional candidate for food preservation, combining antimicrobial efficacy with probiotic benefits. Further studies will purify its bioactive compounds and validate applications in food systems.
BibTeX
@inproceedings{ji2025bifidobacterium,
  author = {Jing Ji and Tiange Li and Baoying Ma and Runzhong Wang},
  title = {{A Bifidobacterium Strain with Antibacterial Activity, Its Antibacterial Characteristics and In Vitro Probiotics Studies}},
  booktitle = {Microorganisms},
  year = {2025},
  doi = {10.3390/microorganisms13061190},
}
Figure